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BACKGROUND: The use of laparoscopic distal pancreatectomy 
(LDP) increased in the past twenty years but the real diffusion 
of this technique is still unknown as well as the type of centers 
(high or low volume) in which this procedure is more frequently 
performed. 
DATA SOURCE: A systematic review was performed to evaluate 
the frequency of LDP in Italy and to compare indications and 
results in high volume centers (HVCs) and in low volume 
centers (LVCs).
RESULTS: From 95 potentially relevant citations identified, only 
5 studies were included. A total of 125 subjects were analyzed, of 
whom 95 (76.0%) were from HVCs and 30 (24.0%) from LVCs. 
The mean number of LDPs performed per year was 6.5. The 
mean number of patients who underwent LDP per year was 8.8 
in HVCs and 3.0 in LVCs (P<0.001). The most frequent lesions 
operated on in HVCs were cystic tumors (62.1%, P<0.001) while, 
in LVCs, solid neoplasms (76.7%, P<0.001). In HVCs, malignant 
neoplasms were treated with LDP less frequently than in LVCs 
(17.9% vs 50.0%, P<0.001). Splenectomy was performed for 
non-oncologic reason frequenter in HVCs than in LVCs (70.2% 
vs 25.0%, P=0.004). The length of stay was shorter in HVCs 
than in LVCs (7.5 vs 11.3, P<0.001). No differences were found 
regarding age, gender, ductal adenocarcinoma treated, operative 
time, conversion, morbidity, postoperative pancreatic fistula, 
reoperation and margin status.
CONCLUSIONS: LDPs were frequently performed in Italy. 
The "HVC approach" is characterized by a careful selection of 
patients undergoing LDP. The "LVC approach" is based on the 
hypothesis that LDPs are equivalent both in short-term and 
long-term results to laparotomic approach. These data are not 
conclusive and they point out the need for a national register of 
laparoscopic pancreatectomy.
(Hepatobiliary Pancreat Dis Int 2014;13:458-463)
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Introduction
The use of laparoscopic distal pancreatectomy (LDP) has increased in the past twenty years.[1] Recent systematic reviews and meta-analyses[2-5] 
have demonstrated the safety and feasibility of LDP 
for benign and malignant pancreatic lesions and have 
reported postoperative outcome advantages with respect 
to an open approach. 
Despite the clinical benefit reported, LDP has 
not yet been considered the gold standard in clinical 
practice, and the exact utilization of the laparoscopic 
approach is still unknown. Rosales-Velderrain et al[6] 
have recently reported that, in the United States, the use 
of LDP for benign and malignant body/tail pancreatic 
lesions is low, accounting for only 15%-27% of all distal 
pancreatectomies. Data regarding the Italian scenario 
are lacking even if at the 45th Annual Meeting of the 
European Pancreatic Club, Balzano et al[7] reported 
a brief description regarding the diffusion of the 
laparoscopic technique for distal pancreatectomy in Italy. 
Our study involved a systematic review and the pooled 
analysis of LDP in Italy. The study aimed to evaluate 
the frequency of LDP and to compare the indications 
and results in high volume centers (HVCs) and in low 
volume centers (LVCs). 
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Methods
Study selection
A systematic literature search was conducted using EMBASE, 
MEDLINE, the Cochrane Library, Scopus, the ISI-Web 
of Science and PubMed databases in order to identify all 
studies published up to 2013 regarding LDP in Italy. The 
search terms used MeSH and non-controlled vocabulary 
terms without MeSH. The search terms were used in logical 
combinations such as "distal pancreatectomy" OR "left 
pancreatectomy" OR "pancreatectomy" AND "laparoscopy" 
OR "laparoscopic" AND "Italy". The related articles found 
were used to broaden the search, and all abstracts, studies 
and citations obtained were reviewed. In addition, the 
references of all the studies included were screened for any 
potentially relevant studies. The search was conducted 
from January 1996 to July 2013.
Inclusion and exclusion criteria
All studies written in English which reported LDP in 
an Italian institution, case series or case-control with at 
least ten patients were included. Finally, if two studies 
were reported by the same institution (and/or authors), 
either the study with the larger sample size or the one of 
higher quality was included. 
Studies which failed to fulfill the inclusion criteria 
were excluded. In addition, the following criteria were 
used to exclude studies: 1) studies without adequate 
data; 2) case-reports, reviews, guidelines, letters to 
editor and abstracts without a full text. All of the studies 
enrolled were published from 2008 to 2013.
Data extraction
Each study was evaluated by two independent 
reviewers (Ricci C and Lazzarini E) for inclusion or 
exclusion from the review using the data included in 
the abstract. The following data were extracted from 
each study: title, authors, year of publication, journal of 
publication, characteristics of the study population, study 
design, age, male/female ratio, pancreatic surgery volume, 
indications for surgery, overall distal pancreatectomy, LDP, 
type of operation (LDP with or without splenectomy), 
operative time, conversion rate, perioperative outcomes, 
status of resection margin (R0/1/2) and number of lymph 
nodes harvested. The choice of the articles included in 
this review was adherent to the quality of reporting of 
meta-analyses (QUOROM) statement[8] and a QUOROM 
flow chart was also obtained in order to allow the 
transparency of the conclusions drawn by the authors.
Outcome of interest and definitions
The aims of this review were to identify the 
frequency of LDP in Italy and to compare the results 
reported in HVCs and LVCs. The primary endpoint was 
the number of LDPs performed per year. The secondary 
endpoints were: surgical indications, operative time, 
conversion rate, splenectomy expected/performed, 
postoperative morbidity, postoperative pancreatic fistula, 
length of stay, reoperation rate and margin status.
The volume of the center was defined according 
to the report by Gouma et al.[9] The operative time 
was defined as the interval from skin incision to 
suture. The postoperative morbidity rate included all 
complications after surgery up to the day of discharge; 
they were classified according to the Clavien-Dindo 
classification.[10] A postoperative pancreatic fistula was 
defined according to the criteria of the International 
Study Group on Pancreatic Fistula.[11] Reoperation was 
defined as any surgical procedure performed in the 
first 30 postoperative days or before discharge from the 
hospital. The length of stay was defined as the interval 
from the day of surgery to the day of discharge.
Statistical analysis
Data were analyzed on an intention-to-treat basis 
where possible. All categorical variables were reported 
as frequency and percentage or as a ratio while the 
continuous variables were described as mean and 
standard deviation. To calculate the mean and standard 
deviation in studies which presented median and range, 
we used a dedicated statistical algorithm.[12] The pooled 
data extracted from HVC and LVC series were analyzed. 
The data were analyzed only when they were extracted 
from at least three different studies. Dichotomous 
variables were analyzed using the odds ratio (OR), 
which represented the odds of an event occurring in 
HVCs or LVCs. An OR>1 indicated that the event was 
more likely in an HVC and the point estimate of the 
OR was considered statistically significant when P<0.05. 
Continuous variables were analyzed using weighted 
mean difference (WMD), indicating the difference 
between the two types of centers while accounting for 
the sample size. The statistical analysis was carried 
out using Review Manager Version 5.2 (The Cochrane 
Collaboration, Software Update, Oxford, London, UK).
Results
Selected studies
The results of the systematic search of the literature in 
accordance with the QUOROM statement are shown in 
Figure. Ninety-five potentially relevant citations were 
identified by a search of the literature published up to 
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July 26, 2013. Forty-four papers were defined duplicate 
publications according to their titles. Of the remaining 
51 references, 14 were excluded by evaluating their 
abstracts because they were either not written in English 
or contained data not pertinent to our endpoints, 28 
were excluded because they were case reports, guidelines, 
reviews or letters to editor. Nine articles were reviewed 
as full texts. Of them, 2 were excluded because they 
had potentially redundant data, reporting data from 
the same institution and authors, and two articles 
were excluded because they contained not-extractable 
data. Finally, 5 studies[13-17] were included in the meta-
analysis (Fig.). On review of the data extraction, there 
was 100% agreement between the two reviewers. The 
characteristics of the studies selected are summarized 
in Tables 1 and 2. All studies included reported similar 
exclusion criteria for laparoscopy as well as severe 
cardiopulmonary dysfunction or encasement of the 
mesenteric-portal vein or the superior mesenteric 
artery. All studies had recently been published (2008 or 
later) and involved at least 10 patients. In a total of 125 
subjects analyzed, 95 (76.0%) were from three HVCs 
and 30 (24.0%) from two LVCs. In all single center 
studies, 1 study was prospective, 4 were retrospective; 2 
were case series, and 3 were case-control studies. 
Pooled data
The mean number of LDPs performed per year 
was 6.5; data on the number of LDP/total distal 
pancreatectomies were extracted from only two studies; 
Fig. Quality of reporting meta-analysis statement.
Table 1. Italian series of LDP included in the study
Studies   n Study design HVC
LDP/
  year
LDP/total
  DP
Pugliese et al[13]   14 Retrospective,
  case series
No   2.8     -
Casadei et al[14]   22 Retrospective,
  case-control
Yes   5.5     -
Butturini et al[15]   43 Retrospective,
  case-control
Yes   6.1 43/116
  (37.1%)
Limongelli et al[16]   16 Retrospective,
  case-control
No   3.2 16/28
  (57.1%)
Braga et al[17]   30 Prospective,
  case series
Yes 15.0     -
Total 125   6.5 59/144
  (41.0%)
-: not-extractable data. HVC: high volume center; LDP: laparoscopic distal 
pancrentectomy.
Table 2. Demographics, and clinical, surgical and pathological data extracted from the included studies (n, %)
Studies Age (yr) M/F
Type of lesion
 OT (min)
Splenectomy
  expected/
  performed
Conv
  rate
Morb
  rate
POPF
  rate
Reop
  rate
LOS
  (d)
R1
Lymph
  node
  harvested
Malignant/
  total
PDAC/
  total
Pugliese et al[13]    60±5 0.27   9/14
  (64.3)
  5/14
  (35.7)
   227±24   9/9 (100)   5/14
  (35.7)
  5/14
  (35.7)
  5/14
  (35.7)
0/14
  (0)
 17±8 0/9
  (0)
        -
Casadei et al[14]    59±16.2 0.22   2/22
  (9.1)
  0/22
  (0)
   225±83   2/18 (11.1)   0/22
  (0)
  6/22
  (27.3)
  2/22
  (9.1)
0/22
  (0)
   8±1.3 0/2
  (0)
        -
Butturini et al[15]         - 0.23   2/43
  (4.7)
  0/43
  (0)
          -   2/24 (8.3)   0/43
  (0)
21/43
  (48.8)
12/43
  (27.9)
4/43
  (9.3)
      - 0/2
  (0)
        -
Limongelli et al[16] 62.1±6.9 0.60   6/16
  (37.5)
  1/16
  (6.3)
   204±31   6/11 (54.5)   1/16
  (6.3)
  4/16
  (25.0)
  3/16
  (18.8)
0/16
  (0)
6.4±2.3 1/6
  (16.7)
        -
Braga et al[17] 55.5±16.2 0.67 13/30
  (43.3)
11/30
  (36.7)
   209±66 13/15 (86.7)   7/30
  (23.3)
14/30
  (46.7)
12/30
  (40.0)
0/30
  (0)
7.1±3.3 0/21
  (0)
15.5±9.2
Total 58.4±12.5 0.36 32/125
  (25.6)
17/125
  (13.6)
215.4±58.1 32/77 (41.6) 13/125
  (10.4)
50/125
  (40.0)
34/125
  (27.2)
4/125
  (3.2)
   9±3.4 1/40
  (2.5)
15.5±9.2
-: not-extractable data; M: male; F: female; PDAC: pancreatic ductal adenocarcinoma; OT: operative time; Conv: conversion; Morb: morbidity; 
POPF: postoperative pancreatic fistula; Reop: reoperation; LOS: length of stay; R1: positive microscopic resection margin.
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Table 3. Comparison between LDP in HCVs and LVCs
Variables n HVC n LVC
OR or WMD
  (95% CI)
P value
LDPs/per year 95   8.8±5.3 30   3.0±0.3     5.80 (4.73, 6.87) <0.001
Male/total (%) 95 24 (25.2) 30   9 (30.0)     0.79 (0.32, 1.95)    0.61
Age (yr) 52 56.9±16.2 30 61.1±6.1   -4.20 (-9.11, 0.71)    0.09
Cystic/total (%) 95 59 (62.1) 30   7 (23.3)     5.38 (2.10, 13.81) <0.001
Solid/total (%) 95 36 (37.9) 30 23 (76.7)     0.19 (0.07, 0.48) <0.001
Malignant/total
  (%)
95 17 (17.9) 30 15 (50.0)     0.22 (0.09, 0.53) <0.001
PDAC/total 95 11 (11.6) 30   6 (20.0)     0.52 (0.18, 1.56)    0.25
OT (min) 52  215±73 30  214±28    1.00 (-21.23, 23.23)    0.93
Conversion rate
  (%)
95   7 (7.4) 30   6 (20.0)     0.32 (0.10, 1.04)    0.06
Morbidity rate
  (%)
95 41 (43.2) 30   9 (30.0)     1.77 (0.73, 4.27)    0.20
POPF rate (%) 95 26 (27.4) 30   8 (26.7)     1.04 (0.41, 2.62)    0.94
Reoperation rate
  (%)
95   4 (4.2) 30   0 (0)     3.00 (0.16, 57.34)    0.47
LOS (d) 52   7.5±2.4 30 11.3±4.6   -3.80 (-5.57, -2.03) <0.001 
Splenectomy
  expected/
  performed
57 17 (29.8) 20 15 (75.0)     0.14 (0.04, 0.45) <0.001 
R1 25   0 (0) 15   1 (6.7)     0.19 (0.01, 4.96)    0.32
HVC: high volume center; LVC: low volume center; OR: odds ratio; WMD: 
weighted mean difference; LDP: laparoscopic distal pancreatectomy; 
PDAC: pancreatic ductal adenocarcinoma; OT: operative time; POPF: 
postoperative pancreatic fistula; LOS: length of stay; R1: positive microscopic 
resection margin.
in 41.0% (59/144) of the patients, a laparoscopic 
approach was used (Table 1). The demographics and 
clinical, surgical and pathological data are shown 
in Table 2. The mean age of the patients was 58.4±
12.5 years (four studies) with a male/female ratio of 
0.36. LDP was performed more frequently for cystic 
lesions (52.8%, 66/125) than for solid lesions (47.2%, 
59/125), giving a cystic/solid lesion ratio of 1.12. LDP 
was done for malignant lesions in 25.6% of the patients, 
and only 13.6% of the patients had pancreatic ductal 
adenocarcinomas (PDACs). In all studies, patients with 
malignant neoplasms were involved, but only three 
centers systematically performed LDPs for body/tail 
resectable PDAC. The mean operative time was 215.4 ±
58.1 minutes (four studies) with a conversion rate of 
10.4% (13/125). LDP with splenectomy was performed in 
61.6% (77/125) of the patients, whereas those performed 
for oncologic reasons accounted for 25.6% (32/125), 
with a splenectomy expected/performed ratio of 0.42. 
The morbidity and postoperative pancreatic fistula rates 
were 40.0% (50/125) and 27.2% (34/125), respectively. 
The reoperation rate was 3.2% and the mean length of 
stay was 9±3.4 days (four studies). R1 resections were 
rarely performed (2.5%, 1/40). Only one study reported 
the mean number of lymph nodes harvested (15.5±9.2). 
Meta-analytic results
The results of the comparison between LDP in 
HVCs and LVCs are shown in Table 3. The number of 
LDPs/total distal pancreatectomies and the number 
of lymph nodes harvested were not analyzed because 
these data were reported by only two studies and one 
study, respectively. The mean number of patients who 
underwent LDP per year was 8.8±5.3 and 3.0±0.3 in 
HVCs and LVCs, respectively, giving a WMD of 5.80 
(4.73, 6.87; P<0.001). The age and gender of the patients 
were similar in the two types of centers with a WMD 
and OR of -4.20 (-9.11, 0.71; P=0.09) and 0.79 (0.32, 1.95; 
P=0.61), respectively. The most frequent lesions operated 
on in HVCs were cystic tumors (62.1%) giving an OR 
of 5.38 (2.10, 13.81; P<0.001) while, in LVCs, the lesions 
were solid neoplasms (76.7%), giving an OR of 0.19 (0.07, 
0.48; P<0.001). In HVCs, malignant neoplasms were 
treated with LDP less frequently than in LVCs (17.9% 
vs 50.0%) corresponding to an OR of 0.22 (0.09, 0.53; 
P<0.001). The number of patients with PDACs who 
were treated was low in both HVCs and LVCs (11.6% 
and 20.0%; P=0.25). The operative time which was 
similar in both HVCs and LVCs resulted in a WMD 
of 1.00 (-21.23, 23.23; P=0.93). LDP with splenectomy 
was performed for oncologic reason more frequently 
in LVCs than in HVCs (75.0% vs 29.8%, respectively) 
with an OR of 0.14 (0.04, 0.45; P<0.001). The conversion 
rate was lower in HVCs than in LVCs, but it was not 
statistically significant (P=0.06). Pooled morbidity, 
postoperative pancreatic fistula and reoperation rates 
were similar in the two types of centers with ORs of 1.77 
(0.73, 4.27; P=0.20), 1.04 (0.41, 2.62; P=0.94) and 3.00 
(0.16, 57.34; P=0.47), respectively. The length of stay 
was statistically shorter in HVCs than in LVCs (7.5±2.4 
vs 11.3±4.6) as shown by a WMD of -3.80 (-5.57, -2.03; 
P<0.001). There were no differences between the two 
types of centers regarding positive resection margins in 
malignant neoplasms (0% vs 6.7%) with an OR of 0.19 
(0.01, 4.96; P=0.32).
Discussion 
LDP has rapidly expanded its application over the last 
decade and, although randomized studies are lacking, 
recent meta-analyses[2-5] have suggested that LDP was safe 
and effective as open distal pancreatectomy. Nevertheless, 
Rosales-Velderrain et al[6] have reported that, in the 
United States, only a low percentage (15%-27%) of patients 
with body/tail pancreatic tumors were subjected to 
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LDP. To our knowledge, there are no data regarding the 
diffusion of LDP in Europe, especially in Italy. Moreover, 
there are no data regarding the different approach to 
LDP for pancreatic surgery in HVCs and LVCs.
Our systematic review included 5 studies on 3 HVCs 
and 2 LVCs. Data regarding the use of the laparoscopic 
approach were extracted from only 2 studies. The review 
showed that 41.0% of patients with body/tail pancreatic 
tumors underwent LDP. This result indicated good 
diffusion of the laparoscopic approach even if LDP was 
not always performed, probably because this approach 
was sometimes not indicated, for example in case of the 
presence of PDACs. The number of LDPs performed in 
Italy per center per year was 6.5 procedures. A pooled 
analysis showed that the mean number of patients 
treated every year with LDP was significantly higher 
in HVCs than in LVCs. These data first suggest that, in 
Italy, high volume pancreatic surgeons did not exclude 
the use of the laparoscopic approach in body/tail 
lesions. In fact, in HVCs, preoperative suspicion of 
malignancy did not exclude laparoscopic approach. 
However, we found that 2 out of 3 HVCs considered 
mini-invasive surgery systematically not suitable for 
PDAC treatment. Regarding the type of lesion, we did 
not find a clear prevalence of cystic or solid lesions in 
Italian laparoscopic series. However, there were some 
statistically significant differences in the types of lesions 
treated when we considered HVCs and LVCs separately. 
In HVCs, the most common indication for LDP was a 
cystic lesion, whereas, in LVCs, it was the presence of a 
solid neoplasm. Malignant lesions were treated in every 
study, accounting for 25.6% of all neoplasms, whereas 
13.6% of the patients had PDACs. Nevertheless, in 
LVCs, a mini-invasive approach was carried out more 
frequently with respect to HVCs for malignant lesions, 
but the indication for patients with PDACs was similar. 
These data suggested that, in Italy, the laparoscopic 
approach was used with prudence in the absence of 
data regarding long-term results, at least in HVCs. This 
approach seems to be similar to those of other European 
countries as reported by Mabrut et al[18] in a study of 
multicentric series. This study, which included all types 
of pancreatic laparoscopic resections, found that the 
most common indication was benign pancreatic disease 
and only 3.9% of patients were affected by PDACs. On 
the other hand, the scenario seems to be different, in 
the United States, LDPs have frequently been used for 
malignant neoplasms. However, Rosales-Velderrain et 
al[6] reported that it is impossible to clearly extract the 
correlation between hospital volume and type of lesion. 
There was no difference in operative time in HVCs and 
LVCs in our study. This finding was dependent on the 
presence of skilled laparoscopic surgeons in both types 
of centers. The low expected/performed splenectomy 
ratio indicated that almost half of the splenectomies 
were performed for technical reasons. Moreover, we 
noted that the ratio was significantly lower in HVCs 
with respect to LVCs. This finding clearly demonstrates 
that the number of splenectomies for non-oncological 
reasons was higher in HVCs than in LVCs. There are 
various reasons which might explain this difference 
including higher oncological prudence in HVCs and/ or 
the advanced laparoscopic expertise of LVC surgeons. 
In fact, as all things are considered, LVCs are advanced 
laparoscopic centers.[19, 20] The conversion rate was higher 
in LVCs than in HVCs, but in LVCs, solid and malignant 
lesions were frequently treated. Pooled morbidity, 
postoperative pancreatic fistula and reoperation rates 
were similar in the two types of centers as has already 
been reported in the United States experience. The 
length of stay was shorter in HVCs than in LVCs as 
described by Balzano et al[21] for laparotomic pancreatic 
surgery. Furthermore, the R1 resection rate was similar 
in HVCs and LVCs.
In conclusion, despite the small sample size 
analyzed, our study showed some differences between 
LDPs performed in HVCs and those performed in LVCs 
in Italy. In our opinion, these differences could reflect 
two different approaches. First, the "HVC approach", 
which represents the point of view of pancreatic 
surgeons, characterized by a careful selection of patients 
undergoing LDP. Second, the "LVC approach", the more 
technical approach, was used by skilled laparoscopic 
surgeons. This point of view hypothesizes equivalent 
oncological results of laparotomic procedures even if 
there is no evidence in the literature. These data are not 
conclusive and they point out the need for a national 
register of laparoscopic pancreatectomies which could 
allow better analyses on larger samples of patients. 
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